Header Logo

Connection

YEVGENIY KHARITON to Female

Back to Details
This is a "connection" page, showing publications YEVGENIY KHARITON has written about Female.
YEVGENIY KHARITON
Connection Strength
0.208
Female
  1. Association Between Sacubitril/Valsartan Initiation and Health Status Outcomes in?Heart?Failure With Reduced Ejection?Fraction. JACC Heart Fail. 2019 11; 7(11):933-941.
    View in: PubMed
    Score: 0.026
  2. Health Status Benefits of Successful?Chronic Total Occlusion Revascularization Across the Spectrum?of?Left Ventricular Function: Insights From the OPEN-CTO Registry. JACC Cardiovasc Interv. 2018 11 26; 11(22):2276-2283.
    View in: PubMed
    Score: 0.025
  3. Guideline-directed statin intensification in patients with new or worsening symptoms of peripheral artery disease. Clin Cardiol. 2018 Nov; 41(11):1414-1422.
    View in: PubMed
    Score: 0.025
  4. Health Status Disparities by Sex, Race/Ethnicity,?and Socioeconomic Status in Outpatients With Heart Failure. JACC Heart Fail. 2018 06; 6(6):465-473.
    View in: PubMed
    Score: 0.024
  5. Health Status Variation Across Practices in Outpatients With Heart Failure: Insights From the CHAMP-HF (Change the Management of Patients With Heart Failure) Registry. Circ Cardiovasc Qual Outcomes. 2018 04; 11(4):e004668.
    View in: PubMed
    Score: 0.024
  6. Impact of transesophageal echocardiography on management in patients with suspected cardioembolic stroke. Am J Cardiol. 2014 Dec 15; 114(12):1912-6.
    View in: PubMed
    Score: 0.019
  7. Association Between Change in Ambulatory Pulmonary Artery Pressures and Natriuretic Peptides in Patients with Heart Failure: Results From the EMBRACE-HF Trial. J Card Fail. 2023 09; 29(9):1324-1328.
    View in: PubMed
    Score: 0.008
  8. The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial. Nat Med. 2021 11; 27(11):1954-1960.
    View in: PubMed
    Score: 0.008
  9. Association Between Change in Ambulatory Hemodynamic Pressures and Symptoms of Heart Failure. Circ Heart Fail. 2021 11; 14(11):e008446.
    View in: PubMed
    Score: 0.008
  10. Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial. Circulation. 2019 10 29; 140(18):1463-1476.
    View in: PubMed
    Score: 0.007
  11. Association of Changes in Heart?Failure Treatment With Patients' Health Status: Real-World Evidence From CHAMP-HF. JACC Heart Fail. 2019 07; 7(7):615-625.
    View in: PubMed
    Score: 0.006
  12. Target Doses of Heart Failure Medical?Therapy and Blood Pressure: Insights From the CHAMP-HF Registry. JACC Heart Fail. 2019 04; 7(4):350-358.
    View in: PubMed
    Score: 0.006
  13. Vaccination Trends in Patients With Heart?Failure: Insights From Get With The Guidelines-Heart Failure. JACC Heart Fail. 2018 10; 6(10):844-855.
    View in: PubMed
    Score: 0.006
  14. Association Between Prompt Defibrillation and Epinephrine Treatment With Long-Term Survival After In-Hospital Cardiac Arrest. Circulation. 2018 05 08; 137(19):2041-2051.
    View in: PubMed
    Score: 0.006
  15. Association of Serial Kansas City Cardiomyopathy Questionnaire Assessments With Death and Hospitalization in Patients With Heart Failure With Preserved and Reduced Ejection Fraction: A Secondary Analysis of 2 Randomized Clinical Trials. JAMA Cardiol. 2017 12 01; 2(12):1315-1321.
    View in: PubMed
    Score: 0.006
  16. Impact of Telemonitoring on Health Status. Circ Cardiovasc Qual Outcomes. 2017 Dec; 10(12).
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.